tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andy Hsieh, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Andy Hsieh works at WILLIAM BLAIR with a stock forecast success ratio of 100% fulfilled within 57 days on average.
Andy Hsieh’s has documented 5 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FGEN, FibroGen at 26-Jun-2023.
Analyst best performing recommendations are on FGEN (FIBROGEN).
The best stock recommendation documented was for FGEN (FIBROGEN) at 8/8/2017. The price target of $56.3 was fulfilled within 57 days with a profit of $6.8 (13.74%) receiving and performance score of 2.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
2
$0.86 (75.44%)
4
8 months 26 days ago
2/7 (28.57%)
$0.56 (38.89%)
133
Sell
2
$0.86 (75.44%)
16
10 months 7 days ago
9/10 (90%)
$-0.51 (-20.32%)
140
Hold
11
$9.86 (864.91%)
10 months 8 days ago
1/6 (16.67%)
$8.29 (305.90%)
389
Hold
35
10 months 8 days ago
2/4 (50%)
$12.89 (58.30%)
15
Hold
3
$1.86 (163.16%)
25
10 months 8 days ago
2/4 (50%)
$0.29 (10.70%)
127
What Year was the first public recommendation made by Andy Hsieh?
